Picardi, M. and Giordano, C. (2021) “Comment on ‘Combining brentuximab vedotin with dexamethasone, high-dose cytarabine and cisplatin as salvage treatment in relapsed or refractory Hodgkin lymphoma: the phase II HOVON/LLPC Transplant BRaVE study.’”, Haematologica. Pavia, Italy, 106(4), pp. 1226-1227. doi: 10.3324/haematol.2020.278203.